Skip to content
10-Q

Quarterly Report

iBio, Inc. IBIO

0001420720-26-000004

← back to feed
Filed
Feb 10, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Feb 9, 2026 34.54M sh
Shares Diluted Q2 2026 · Dec 31, 2025 99.13M sh
Shares Diluted Q2 2026 · Dec 31, 2025 76.03M sh
Shares Diluted Q2 2026 · Dec 31, 2024 9.13M sh
Shares Diluted Q2 2026 · Dec 31, 2024 8.88M sh
Capex Q2 2026 · Dec 31, 2025 $548K
Capex Q2 2026 · Dec 31, 2024 $1K
Operating Cash Flow Q2 2026 · Dec 31, 2025 −$10.91M
Operating Cash Flow Q2 2026 · Dec 31, 2024 −$7.58M
Cash And Equivalents Q2 2026 · Dec 31, 2025 $28.67M
Cash And Equivalents Q2 2026 · Jun 30, 2025 $8.58M
Stockholders Equity Q2 2026 · Dec 31, 2025 $56.56M
Stockholders Equity Q2 2026 · Jun 30, 2025 $14.88M
Current Liabilities Q2 2026 · Dec 31, 2025 $5.9M
Current Liabilities Q2 2026 · Jun 30, 2025 $6.11M
Total Liabilities Q2 2026 · Dec 31, 2025 $7.83M
Total Liabilities Q2 2026 · Jun 30, 2025 $8.31M
Current Assets Q2 2026 · Dec 31, 2025 $53.37M
Current Assets Q2 2026 · Jun 30, 2025 $9.72M
Total Assets Q2 2026 · Dec 31, 2025 $64.39M
Total Assets Q2 2026 · Jun 30, 2025 $23.19M
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.09
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.19
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.48
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.94
Eps Basic Q2 2026 · Dec 31, 2025 −$0.09
Eps Basic Q2 2026 · Dec 31, 2025 −$0.19
Eps Basic Q2 2026 · Dec 31, 2024 −$0.48
Eps Basic Q2 2026 · Dec 31, 2024 −$0.94
Sga Expense Q2 2026 · Dec 31, 2025 $5.17M
Sga Expense Q2 2026 · Dec 31, 2025 $7.67M
Sga Expense Q2 2026 · Dec 31, 2024 $2.74M
Sga Expense Q2 2026 · Dec 31, 2024 $5.54M
Rd Expense Q2 2026 · Dec 31, 2025 $4.28M
Rd Expense Q2 2026 · Dec 31, 2025 $7.83M
Rd Expense Q2 2026 · Dec 31, 2024 $1.88M
Rd Expense Q2 2026 · Dec 31, 2024 $3.18M
Net Income Q2 2026 · Dec 31, 2025 −$8.99M
Net Income Q2 2026 · Dec 31, 2025 −$14.71M
Net Income Q2 2026 · Sep 30, 2025 −$5.72M
Net Income Q2 2026 · Dec 31, 2024 −$4.36M
Net Income Q2 2026 · Dec 31, 2024 −$8.35M
Net Income Q2 2026 · Sep 30, 2024 −$3.99M
Operating Income Q2 2026 · Dec 31, 2025 −$9.45M
Operating Income Q2 2026 · Dec 31, 2025 −$15.4M
Operating Income Q2 2026 · Dec 31, 2024 −$4.42M
Operating Income Q2 2026 · Dec 31, 2024 −$8.53M
Revenue Q2 2026 · Dec 31, 2025 $0
Revenue Q2 2026 · Dec 31, 2025 $100K
Revenue Q2 2026 · Dec 31, 2024 $200K
Revenue Q2 2026 · Dec 31, 2024 $200K